NCT06614946 Improving Coping to Reduce Suicide Risk Following ED Discharge
| NCT ID | NCT06614946 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Suicidal |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-05-12 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-05-12 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The researchers hope to learn whether an electronic safety plan (ESP) and a supportive text messaging program are feasible and acceptable to adult patients with recent suicidal thoughts or behavior after emergency department (ED) discharge. From this study, the researchers also hope to learn how to best carry out the ESP and text messaging program to improve outcomes for patients after ED discharge.
Eligibility Criteria
Inclusion Criteria: Individuals presenting to an ED with either: 1. actual, interrupted, or aborted attempt in the last 4 weeks 2. suicidal ideation within the last week Exclusion Criteria: * Severe cognitive impairment or altered mental status (psychosis, manic state) * Severe aggression/agitation, * Being admitted or transferred into inpatient care, * Patient not owning a cell phone with text messaging capability
Contact & Investigator
Ewa Czyz, Ph.D.
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT06614946 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Suicidal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06614946 currently recruiting?
Yes, NCT06614946 is actively recruiting participants. Contact the research team at ewac@umich.edu for enrollment information.
Where is the NCT06614946 trial being conducted?
This trial is being conducted at Ann Arbor, United States.
Who is sponsoring the NCT06614946 clinical trial?
NCT06614946 is sponsored by University of Michigan. The principal investigator is Ewa Czyz, Ph.D. at University of Michigan. The trial plans to enroll 120 participants.